Page results
-
This information is for patients, (and their family and carers), who are considering having Uterine Artery (Fibroid) Embolisation (UAE). It explains what is involved and the possible risks.
-
UCLH has been selected as the lead site in Great Britain for Neuralink’s GB-PRIME study, a clinical investigation for Neuralink’s brain-computer interface (BCI).
-
It is important to make sure you are eating and drinking well before your surgery. Good nutrition will also help you recover after your surgery.
-
This information is for patients who have attended the emergency department with an undisplaced or minimally displaced fracture (broken bone) at the base of your 5th metatarsal.
-
Tasnim tells us about her experience training with the Pharmacy team at UCLH and how their support has encouraged her to pursue this career.
-
Today we are launching the new UCLH strategy for 2023-2027. Developed with staff, patients and key partners, the strategy sets the future direction of UCLH over the next five years.
-
This page has been written for patients who are having a course of superficial radiotherapy for a skin tumour (such as a basal cell carcinoma or squamous cell carcinoma), or some other skin condition.
-
This page is for patients who are having stereotactic ablative body radiotherapy (SABR) for lung cancer.
-
This information has been written to help you now that your radiotherapy treatment is finishing.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the neck, chest, abdomen, and pelvis.
File results
-
FOI/2023/0453 - Patient transport home bookings
-
FOI/2023/0455 - NHS remediating elective surgery operations
-
FOI/2023/0457 - Psychiatric/ behavioural problems linked to psychiatric disorders use of force policies
-
FOI/2023/0458 - Patient trolleys
-
FOI/2023/0459 - Multiple myeloma treatment
-
FOI/2023/0461 - UCLH operating system software/ data centres hybrid cloud
-
FOI/2023/0462 - Patients to hotels
-
FOI/2023/0463 - Extravasation injuries
-
FOI/2023/0466 - Language services (interpreting and translation services)
-
FOI/2023/0471 - Treatment of HIV & PrEP